Turki Rashed Alnafisah

King Saud bin Abdulaziz University for Health Sciences

Papers

1

Total Citations

3

H-Index

1

About

Turki Rashed Alnafisah is a dedicated urological surgeon and researcher whose work centers on the delicate balance between oncological efficacy and organ preservation in renal cell carcinoma (RCC). His key research areas include nephron-sparing surgery, functional outcomes following renal procedures, and the surgical management of locally advanced kidney cancer. Dr. Alnafisah’s major contribution is his comparative study on partial versus total nephrectomies in T3 stage RCC, which challenges conventional surgical dogma. By demonstrating that partial nephrectomy can preserve renal function without compromising oncological control in select patients with pT3a disease, his work provides critical evidence for expanding the indications of nephron-sparing surgery. This study, published in 2023, has already garnered attention within the urology community, accumulating 3 citations in a short period—a promising sign of its growing influence. Dr. Alnafisah’s research is particularly impactful for clinicians seeking to optimize patient quality of life post-surgery while maintaining rigorous cancer clearance. His findings contribute to a paradigm shift in urological oncology, advocating for more personalized, function-preserving approaches even in advanced tumor stages.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Preserving Renal Function without Compromising Oncological Outcomes: A Comparative Study of Partial and Total Nephrectomies in T3 Stage Renal Cell Carcinoma
3 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: King Saud bin Abdulaziz University for Health Sciences

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago